I am an Imperial College Research Fellow at the MRC Centre for Global Infectious Disease Analysis. I work on mathematical models of infectious diseases, focussed on childhood diseases and the public health impact of new vaccines.
The main focus of my current research is to develop dynamic models for respiratory synctial virus (RSV) transmission and vaccination, to inform target product profiles for RSV vaccine in low-income settings.
I also work on a range of other projects related to estimating the public health impact of the RTS,S/AS01 malaria vaccine and second-generation malaria vaccines in malaria endemic areas.
Before joining the Department of Infectious Disease Epidemiology at Imperial College London, I completed my PhD program at the Research School of Population Health at the Australian National University.
A full list of publications is at www.alexandrahogan.com.
et al., 2023, Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study., Plos Med, Vol:20
et al., 2023, Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach, Nature Communications, Vol:14, ISSN:2041-1723, Pages:1-10
et al., 2023, Quantifying the impact of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study, The Lancet Public Health, Vol:8, ISSN:2468-2667, Pages:e174-e183
et al., 2022, Seasonal use case for the RTS,S/AS01 malaria vaccine: a mathematical modelling study, The Lancet Global Health, Vol:10, ISSN:2214-109X, Pages:e1782-e1792
et al., 2022, Global impact of the first year of COVID-19 vaccination: a mathematical modelling study, Lancet Infectious Diseases, Vol:22, ISSN:1473-3099, Pages:1293-1302